BACKGROUND: The Emergency Department Assessment of Chest pain Score-Accelerated Diagnostic Protocol (EDACS-ADP) is a decision aid designed to safely identify emergency department (ED) patients with chest pain for early discharge. Derivation and validation studies in Australasia have demonstrated high sensitivity (99%-100%) for major adverse cardiac events (MACE). OBJECTIVES: To validate the EDACS-ADP in a cohort of US ED patients with symptoms suspicious for acute coronary syndrome (ACS). METHODS: A secondary analysis of participants enrolled in the HEART Pathway Randomized Controlled Trial was conducted. This single-site trial enrolled 282 ED patients≥21 years old with symptoms concerning for ACS, inclusive of all cardiac risk levels. Each patient was classified as low risk or at risk by the EDACS-ADP based on EDACS, electrocardiogram, and serial troponins. Potential early discharge rate and sensitivity for MACE at 30 days, defined as cardiac death, myocardial infarction (MI), or coronary revascularization were calculated. RESULTS:MACE occurred in 17/282 (6.0%) participants, including no deaths, 16/282 (5.6%) with MI, and 1/282 (0.4%) with coronary revascularization without MI. The EDACS-ADP identified 188/282 patients [66.7%, 95% confidence interval (CI): 60.8%-72.1%] as low risk. Of these, 2/188 (1.1%, 95% CI: 0.1%-3.9%) had MACE at 30 days. EDACS-ADP was 88.2% (95% CI: 63.6%-98.5%) sensitive for MACE, identifying 15/17 patients. Of the 2 patients identified as low risk with MACE, 1 had MI and 1 had coronary revascularization without MI. CONCLUSIONS: Within a US cohort of ED patients with symptoms concerning for ACS, sensitivity for MACE was 88.2%. We are unable to validate the EDACS-ADP as sufficiently sensitive for clinical use.
RCT Entities:
BACKGROUND: The Emergency Department Assessment of Chest pain Score-Accelerated Diagnostic Protocol (EDACS-ADP) is a decision aid designed to safely identify emergency department (ED) patients with chest pain for early discharge. Derivation and validation studies in Australasia have demonstrated high sensitivity (99%-100%) for major adverse cardiac events (MACE). OBJECTIVES: To validate the EDACS-ADP in a cohort of US ED patients with symptoms suspicious for acute coronary syndrome (ACS). METHODS: A secondary analysis of participants enrolled in the HEART Pathway Randomized Controlled Trial was conducted. This single-site trial enrolled 282 ED patients≥21 years old with symptoms concerning for ACS, inclusive of all cardiac risk levels. Each patient was classified as low risk or at risk by the EDACS-ADP based on EDACS, electrocardiogram, and serial troponins. Potential early discharge rate and sensitivity for MACE at 30 days, defined as cardiac death, myocardial infarction (MI), or coronary revascularization were calculated. RESULTS: MACE occurred in 17/282 (6.0%) participants, including no deaths, 16/282 (5.6%) with MI, and 1/282 (0.4%) with coronary revascularization without MI. The EDACS-ADP identified 188/282 patients [66.7%, 95% confidence interval (CI): 60.8%-72.1%] as low risk. Of these, 2/188 (1.1%, 95% CI: 0.1%-3.9%) had MACE at 30 days. EDACS-ADP was 88.2% (95% CI: 63.6%-98.5%) sensitive for MACE, identifying 15/17 patients. Of the 2 patients identified as low risk with MACE, 1 had MI and 1 had coronary revascularization without MI. CONCLUSIONS: Within a US cohort of ED patients with symptoms concerning for ACS, sensitivity for MACE was 88.2%. We are unable to validate the EDACS-ADP as sufficiently sensitive for clinical use.
Authors: C P Cannon; A Battler; R G Brindis; J L Cox; S G Ellis; N R Every; J T Flaherty; R A Harrington; H M Krumholz; M L Simoons; F J Van De Werf; W S Weintraub; K R Mitchell; S L Morrisson; R G Brindis; H V Anderson; D S Cannom; W R Chitwood; J E Cigarroa; R L Collins-Nakai; S G Ellis; R J Gibbons; F L Grover; P A Heidenreich; B K Khandheria; S B Knoebel; H L Krumholz; D J Malenka; D B Mark; C R Mckay; E R Passamani; M J Radford; R N Riner; J B Schwartz; R E Shaw; R J Shemin; D B Van Fossen; E D Verrier; M W Watkins; D R Phoubandith; T Furnelli Journal: J Am Coll Cardiol Date: 2001-12 Impact factor: 24.094
Authors: Y Fu; W C Chang; D Mark; R M Califf; B Mackenzie; C B Granger; E J Topol; M Hlatky; P W Armstrong Journal: Circulation Date: 2000-09-19 Impact factor: 29.690
Authors: Judd E Hollander; Andra L Blomkalns; Gerard X Brogan; Deborah B Diercks; John M Field; J Lee Garvey; W Brian Gibler; Timothy D Henry; James W Hoekstra; Brian R Holroyd; Yuling Hong; J Douglas Kirk; Brian J O'Neil; Raymond E Jackson; Tom Aufderheide; Andra L Blomkalns; Gerard X Brogan; James Christenson; Sean Collins; Deborah B Diercks; Francis M Fesmire; J Lee Garvey; Gary B Green; Christopher J Lindsell; W Frank Peacock; Charles V Pollack; Robert Zalenski Journal: Ann Emerg Med Date: 2004-12 Impact factor: 5.721
Authors: Judd E Hollander; Andra L Blomkalns; Gerard X Brogan; Deborah B Diercks; John M Field; J Lee Garvey; W Brian Gibler; Timothy D Henry; James W Hoekstra; Brian R Holroyd; Yuling Hong; J Douglas Kirk; Brian J O'Neil; Raymond E Jackson Journal: Acad Emerg Med Date: 2004-12 Impact factor: 3.451
Authors: Jeffrey A Kline; Alice M Mitchell; Michael S Runyon; Alan E Jones; William B Webb Journal: Acad Emerg Med Date: 2005-09-15 Impact factor: 3.451
Authors: William E Boden; Robert A O'Rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William J Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; Bernard R Chaitman; Leslee Shaw; Gilbert Gosselin; Shah Nawaz; Lawrence M Title; Gerald Gau; Alvin S Blaustein; David C Booth; Eric R Bates; John A Spertus; Daniel S Berman; G B John Mancini; William S Weintraub Journal: N Engl J Med Date: 2007-03-26 Impact factor: 91.245
Authors: Padma Kaul; Wei-Ching Chang; A Michael Lincoff; Philip Aylward; Amadeo Betriu; Christoph Bode; Robert M Califf; E Magnus Ohman; Victor Guetta; P Gabriel Steg; Frans Van de Werf; Paul W Armstrong Journal: Eur Heart J Date: 2006-04-11 Impact factor: 29.983
Authors: Jason Stopyra; Anna Catherine Snavely; Brian Hiestand; Brian J Wells; Kristin Macfarlane Lenoir; David Herrington; Nella Hendley; Nicklaus P Ashburn; Chadwick D Miller; Simon A Mahler Journal: Heart Date: 2020-04-08 Impact factor: 5.994
Authors: Andrew D McRae; Grant Innes; Michelle Graham; Eddy Lang; James E Andruchow; Yunqi Ji; Shabnam Vatanpour; Tasnima Abedin; Hong Yang; Danielle A Southern; Dongmei Wang; Isolde Seiden-Long; Lawrence DeKoning; Peter Kavsak Journal: Acad Emerg Med Date: 2017-08-11 Impact factor: 3.451
Authors: Maite Anna Huis In 't Veld; Louise Cullen; Simon A Mahler; Barbra E Backus; Zachary D W Dezman; Amal Mattu Journal: West J Emerg Med Date: 2017-02-27